﻿<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="http://medrxiv.org">
<admin:errorReportsTo rdf:resource="mailto:medrxiv@cshlpress.edu"/>
<title>medrxiv Subject Collection: Addiction Medicine</title>
<link>http://medrxiv.org</link>
<description>
This feed contains articles for medRxiv Subject Collection "Addiction Medicine"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.23.26356355v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.17.26355906v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.10.26355118v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.08.26355193v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.04.26353616v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.26.26354041v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.28.26354329v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.27.26354253v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.26.26354113v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.20.26353682v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.23.26353953v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.15.26351052v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.15.26353305v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.11.26352941v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.05.08.26352752v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.28.26351962v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.25.26350029v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.17.26351044v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.23.26351366v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.17.26351089v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.13.26350800v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.15.26350988v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.14.26350880v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.10.26350655v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.11.26350657v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.03.26348150v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.04.01.26349949v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.03.26.26349460v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.03.17.26348617v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.03.16.26348531v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>medrxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>medrxiv</title>
<url>https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png</url>
<link>http://medrxiv.org</link>
</image>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.23.26356355v1?rss=1">
<title>
<![CDATA[
Associations Between TMS-Induced Electric Fields and Craving and Consumption Outcomes in Substance Use Disorders: A Multimodal Dose-Response Meta-Analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.23.26356355v1?rss=1
</link>
<description><![CDATA[
BackgroundTranscranial magnetic stimulation (TMS) is a promising treatment for substance use disorders (SUDs), although heterogeneous stimulation parameters hinder the identification of optimal strategies. Using meta-modeling, we linked treatment effect sizes (Hedges g) to simulated electric field (E-field) distributions to identify brain regions associated with efficacy variability.

MethodsTMS trials in individuals with SUDs published through the end of 2025 were identified through a systematic PubMed search. Studies reporting craving or consumption outcomes with quantifiable effect sizes were included. Objectives were to (i) examine associations between study-level effect sizes and simulated local E-field strength in MNI space for craving and consumption outcomes; (ii) generate a combined E-field-effect size association map; and (iii) assess spatial overlap with fMRI drug cue-reactivity patterns in 60 individuals with SUDs.

ResultsThe analysis included 81 randomized controlled TMS studies, yielding 107 effect size estimates for craving and consumption (n = 75 and n = 32, respectively). Compared with sham stimulation, TMS produced small-to-moderate improvements in both outcomes. E-field modeling identified the pre-supplementary motor area (pre-SMA) and inferior frontal gyrus (IFG) as regions associated with variability in craving-related effect sizes, and the frontopolar cortex with variability in consumption-related effect sizes. Correlation maps were highly robust (mean leave-one-out similarity r = 0.996), and the frontopolar cluster showed significant spatial overlap with fMRI drug cue-reactivity patterns (Dice coefficient = 0.37).

ConclusionThese findings identify frontopolar, pre-SMA, and IFG regions where local E-field strength is associated with SUD treatment effects, supporting more precise neuromodulation strategies.
]]></description>
<dc:creator><![CDATA[ Soleimani, G., Paulus, M. P., Ekhtiari, H., Opitz, A. ]]></dc:creator>
<dc:date>2026-06-25</dc:date>
<dc:identifier>doi:10.64898/2026.06.23.26356355</dc:identifier>
<dc:title><![CDATA[Associations Between TMS-Induced Electric Fields and Craving and Consumption Outcomes in Substance Use Disorders: A Multimodal Dose-Response Meta-Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.17.26355906v1?rss=1">
<title>
<![CDATA[
Why drinking episodes escalate differently: Event-level pathways linking hazardous alcohol consumption and sexual risk 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.17.26355906v1?rss=1
</link>
<description><![CDATA[
BackgroundAlcohol-involved drinking episodes vary in whether they involve hazardous alcohol consumption alone, near-miss sexual risk, or sexual risk behavior, but the within-event mechanisms underlying this variability remain unclear.

MethodsGuided by syndemic theory, we conducted a qualitative event-level analysis using modified grounded theory among adults in the San Francisco Bay Area who reported hazardous alcohol consumption, defined as an Alcohol Use Disorder Identification Test score [&ge;]16. In-depth interviews elicited narratives of recent heavy drinking episodes and yielded 64 discrete drinking events across 22 participants. We focused on 35 events with evidence of within-event interaction between biopsychosocial and contextual factors. Using constant comparison, we identified escalation pathways, characterized interruption, and examined how events diverge into three outcomes: hazardous alcohol consumption only, hazardous alcohol consumption with near-miss sexual risk (when risk was plausible but not enacted), and hazardous alcohol consumption with sexual risk behavior.

ResultsTwo primary escalation pathways emerged. Dose-driven escalation involved cumulative alcohol or substance exposure that progressively impaired awareness and self-regulation. Meaning-driven escalation involved prioritizing connection, intimacy, or belonging despite awareness of risk. Time-driven continuation extended exposure across contexts and amplified both pathways. Hazardous alcohol consumption-only events more often followed dose-driven pathways, whereas events involving sexual risk behavior more often followed meaning-driven pathways. Near-miss events occurred across both pathways and illustrated how interruption before the escalation constraint point, when the capacity to modify behavior became reduced, could redirect escalation before sexual risk behavior occurred. Across events with similar levels of intoxication narratives, outcomes diverged according to when the interruption occurred and whether it altered escalation.

ConclusionHazardous drinking episodes diverge into different outcomes based on escalation pathways and the timing and effectiveness of interruption. Early and effective interruption before the escalation constraint point may represent a key target for harm-reduction strategies to prevent progression to sexual risk behavior.
]]></description>
<dc:creator><![CDATA[ Ngo, T. P., Dunham, A. E., Santos, G.-M. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.17.26355906</dc:identifier>
<dc:title><![CDATA[Why drinking episodes escalate differently: Event-level pathways linking hazardous alcohol consumption and sexual risk]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.10.26355118v1?rss=1">
<title>
<![CDATA[
Age as a moderator of a brief alcohol intervention among injury patients in Northern Tanzania 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.10.26355118v1?rss=1
</link>
<description><![CDATA[
BackgroundAlcohol use is a leading modifiable risk factor for injury in sub-Saharan Africa. In Tanzania, young people ([&le;]24 years) experience greater alcohol-related harm despite drinking less frequently than adults. Punguza Pombe kwa Afya Yako (PPKAY) is a culturally adapted, brief intervention for injury patients in Tanzania. This study examined whether age moderates its effectiveness.

MethodsWe conducted an exploratory secondary analysis of baseline and 3-month data from the PPKAY randomized trial among injury patients aged [&ge;]18 years at Kilimanjaro Christian Medical Centre, Tanzania. Eligible participants reporting alcohol use before injury, AUDIT [&ge;]8, or positive breathalyzer were randomized to usual care or PPKAY with SMS boosters. The primary outcome was binge drinking days. Count outcomes were analyzed using negative binomial regression with robust SEs and continuous outcomes using mixed-effects models. Effect modification was assessed using a three-way interaction (Time x intervention x Age).

ResultsAmong 543 participants (mean age 36.8 years; 16.2% aged 18-24), age moderated the intervention effect for drinking days (IRR = 0.27, 95% CI 0.07-0.98; p = 0.046) and drinks consumed (IRR = 0.17, 95% CI 0.04-0.77; p = 0.021). The intervention reduced 4 drinking days (95% CI -7.1 to -0.8) and 27.5 drinks (95% CI -42.8 to -12.2) among young people, while adults showed reductions in both arms, without intervention-specific effect.

ConclusionThe effects of ED-based brief alcohol interventions are not uniform, varying across both age groups and alcohol-related outcomes. We found a greater responsiveness in drinking frequency and quantity reported among young people.
]]></description>
<dc:creator><![CDATA[ Mwita, W. C., Nickenig Vissoci, J. R. C., de Souza, J. V. P., Phillips, A. J., Moshi, B., Madundo, K., Muro, F. J., Mmbaga, B. T., Msuya, S. E., Staton, C. A. ]]></dc:creator>
<dc:date>2026-06-18</dc:date>
<dc:identifier>doi:10.64898/2026.06.10.26355118</dc:identifier>
<dc:title><![CDATA[Age as a moderator of a brief alcohol intervention among injury patients in Northern Tanzania]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.08.26355193v1?rss=1">
<title>
<![CDATA[
Behavioral and Functional Neuroimaging Effects of Delivering a Course of Repetitive Transcranial Magnetic Stimulation to Personalized Targets Within the Ventrolateral Or Dorsolateral Prefrontal Cortex in Treatment-Seeking Participants with Cannabis Use Disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.08.26355193v1?rss=1
</link>
<description><![CDATA[
BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is a promising treatment across addictive disorders including Cannabis Use Disorder (CUD). Stimulation of two rTMS-targets, the ventromedial prefrontal cortex (vmPFC) and the left dorsolateral prefrontal cortex (LDLPFC), limbic and executive control network hubs respectively, may yield differential effects. In this pilot trial, we explored the differential effects of 36-sessions of rTMS applied to either the vmPFC or LDLPFC.

MethodsTreatment-seeking participants with moderate or severe CUD (n=20, 10F, age=33.3{+/-}9.8SD) were randomized to 36-sessions of open-label rTMS (two sessions-per-visit, two or three visits-per-week) to either the LDLPFC (3000-pulses; 10Hz) or vmPFC (900-pulses; 1Hz) using personalized functional Magnetic Resonance Imaging (fMRI) targets along with three-sessions of Motivational Enhancement Therapy. At baseline and following rTMS, the Time-Line Follow-Back was used to measure Days-per-week of cannabis use and the fMRI Regulation of Craving (ROC) task was used to measure network activation to cues associated with long-term negative ( Later) and short-term positive ( Now) consequences of cannabis use.

ResultsEighty percent of participants completed study-rTMS. There was a significant decrease in days-per-week of cannabis use in both groups (vmPFC: d=7.9; DLPFC, d=3.1) between the four-weeks of baseline and seven-weeks of follow-up. LDPFC-rTMS reduced fMRI BOLD signal magnitude and increased LDLPFC functional connectivity in response to cues, while vmPFC-TMS reduced functional connectivity.

ConclusionsTreatment-seeking participants with CUD reduced the number of days-per-week they used cannabis when receiving rTMS applied to either the LDPFC or vmPFC, while fMRI effects differed by treatment target. Future larger sham-controlled trials are needed for efficacy and biomarker determination.
]]></description>
<dc:creator><![CDATA[ McCalley, D., Wong, B., Geoly, A., Struckman, W., Azeez, A., Kaloiani, I., Kim, B., Ninomiya, S., Ehrie, J., Austelle, C. W., Rolle, C. E., Kim, J. P., Froeliger, B., McRae-Clark, A. L., Sahlem, G. ]]></dc:creator>
<dc:date>2026-06-10</dc:date>
<dc:identifier>doi:10.64898/2026.06.08.26355193</dc:identifier>
<dc:title><![CDATA[Behavioral and Functional Neuroimaging Effects of Delivering a Course of Repetitive Transcranial Magnetic Stimulation to Personalized Targets Within the Ventrolateral Or Dorsolateral Prefrontal Cortex in Treatment-Seeking Participants with Cannabis Use Disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.04.26353616v1?rss=1">
<title>
<![CDATA[
Adapting a Regulation of Craving Magnetic Resonance Imaging Task to Generate Functional Repetitive Transcranial Magnetic Stimulation Targets for the Ventromedial and Dorsolateral Prefrontal Cortex in Treatment-Seeking Participants with Cannabis Use Disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.04.26353616v1?rss=1
</link>
<description><![CDATA[
BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is a promising treatment across addictive disorders including Cannabis Use Disorder (CUD). Targeting incentive-salience circuitry via the ventromedial prefrontal cortex (vmPFC) and central-executive circuitry via the left dorsolateral prefrontal cortex (LDLPFC) are both promising treatment approaches; however, to date structural targets have predominated whereas functional targeting may allow for more precision. In this pilot trial we adapted a functional Magnetic Resonance Imaging (fMRI) Regulation of Craving (ROC) task to generate fMRI-based rTMS targets in the vmPFC and LDLPFC.

MethodsWe recruited treatment-seeking participants with moderate or severe CUD as a part of an open-label trial and administered an adapted ROC-task during fMRI following 24-hours of cannabis abstinence. We identified sub-portions of maximal activation of the LDLPFC when participants thought of long-term consequences of cannabis use (Later) and of the vmPFC when participants thought of short-term positive aspects of cannabis use (Now). We hypothesized that our task would generate acceptable rTMS targets in >66% of baseline fMRI scans.

ResultsA total of 20-participants enrolled in the trial (50%F, age=33.3{+/-}9.8) and completed the baseline fMRI. The adapted ROC-task elicited group level activation in the LDLPFC and precuneus in the Later>Now and in the bilateral vmPFC, ACC, and striatum in the Now>Later contrast. Acceptable functional targets resolved in both the vmPFC and LDLPFC in 19 of 20 participants (one participant did not tolerate MRI).

ConclusionsThe adapted ROC-task elicits activation in incentive salience and central executive circuitry and can feasibly generate rTMS targets when using a cluster selection algorithm.
]]></description>
<dc:creator><![CDATA[ Geoly, A., McCalley, D. M., Struckmann, W., Azeez, A., Wong, B., Kim, B., Ninomiya, S., Ahmed, S., Kim, J. P., McRae-Clark, A. L., Froeliger, B., Sahlem, G. L. ]]></dc:creator>
<dc:date>2026-06-06</dc:date>
<dc:identifier>doi:10.64898/2026.06.04.26353616</dc:identifier>
<dc:title><![CDATA[Adapting a Regulation of Craving Magnetic Resonance Imaging Task to Generate Functional Repetitive Transcranial Magnetic Stimulation Targets for the Ventromedial and Dorsolateral Prefrontal Cortex in Treatment-Seeking Participants with Cannabis Use Disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.26.26354041v1?rss=1">
<title>
<![CDATA[
Baseline Gut Microbiome-Metabolome Signatures Are Associated with Drinking Severity and Reduction Following Dutasteride Treatment in Alcohol Use Disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.26.26354041v1?rss=1
</link>
<description><![CDATA[
The gut microbiome has been implicated in alcohol use disorder (AUD), but its relationship to drinking intensity and treatment response remains poorly understood. We conducted a longitudinal multi-omics analysis of stool samples collected at baseline and endpoint (after 12 weeks) from 122 participants enrolled in a double-blind, placebo-controlled trial of dutasteride for AUD. Gut microbiome composition was characterized using 16S rRNA gene sequencing, and fecal metabolites were measured by LC-MS-based metabolomics. At baseline, drinking intensity was associated with increasingly lower microbial richness. Genera in the class Clostridia emerged as key microbial hubs associated with drinking intensity in an age- and sex-dependent manner. Drinking intensity promoted co-enrichment of [Ruminococcus] gnavus group and [Clostridium] inocuum group with amino acid catabolites, as well as the co-depletion of diverse Clostridia taxa and lipid metabolites. Dutasteride treatment and drinking reduction had minimal impact on gut microbiome composition. Random forest models integrating baseline clinical, microbiome, and metabolome data improved the classification of clinically meaningful drinking reduction compared to models using clinical data alone. These findings show that a coupled baseline gut microbiome-metabolome signature is associated with drinking intensity and future treatment response in AUD, highlighting the potential for multi-omics integration to inform precision treatment approaches.
]]></description>
<dc:creator><![CDATA[ Dedon, L. R., Lee, D. J., Lin, Q., Yuan, H., Chi, J., Li, L., Gu, H., Tennen, H., Covault, J. M., Zhou, Y. ]]></dc:creator>
<dc:date>2026-06-02</dc:date>
<dc:identifier>doi:10.64898/2026.05.26.26354041</dc:identifier>
<dc:title><![CDATA[Baseline Gut Microbiome-Metabolome Signatures Are Associated with Drinking Severity and Reduction Following Dutasteride Treatment in Alcohol Use Disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.28.26354329v1?rss=1">
<title>
<![CDATA[
Opioid crisis in Germany? Insights from a cross-sectional nationwide survey within the German drug scene. 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.28.26354329v1?rss=1
</link>
<description><![CDATA[
Background and AimsSynthetic opioids cause tens of thousands of deaths each year in North America, and there are indications that synthetic opioids are also becoming increasingly prevalent in the European drug market. This study aimed to examine high-risk substance use in the German drugusing community with a particular focus on the synthetic opioids fentanyl and nitazenes and related awareness, concerns, overdose experiences, and harm-reduction behavior.

DesignCross-sectional, observational online survey.

SettingOpen drug-use scenes, addiction clinics, and substitution practices at numerous geographic locations throughout Germany, August to September 2025.

Participants235 individuals aged 14+ from the drug using community (mean age 43.4 years; 57.9% male), 79.6% recruited by peers in open drug-use scenes.

MeasurementsThe primary outcome was substances used within the past 12 months. In addition, sources, forms, routes of administration, and perceived changes in availability and price of (synthetic) opioids were assessed as well as risk perceptions, fears, harm-reduction behavior, and overdose-related experiences.

Findings227 respondents reported substance use with an average of 6.2 substances, and 73.1% (95% confidence interval [CI] = 67.0-78.5%) had used at least one opioid in the past year. Synthetic opioids were consumed in many parts of Germany and across all age and gender groups. Among participants who experienced a shortage of their primary opioid in the past year, 25% (95% CI = 15.8-37.2%) reported having used fentanyl instead. 56.5% (95% CI = 36.8-74.3%) of individuals using synthetic opioids reported having experienced an overdose in the past twelve months. Most of the respondents perceived synthetic opioids as posing a high risk, and a substantial proportion expressed fear that they could be mixed into their own substances. However, only 9.9% (95% CI = 6.6-14.7%) use drug checking, although the vast majority stated they would use it if it were available to them.

ConclusionsSynthetic opioids, including fentanyl and nitazenes, have entered the German drug scene, with users reporting high rates of overdose and limited access to harm reduction measures. Germany may be in an early phase of a synthetic opioid transition, warranting urgent expansion of surveillance, naloxone distribution, and drug checking services.
]]></description>
<dc:creator><![CDATA[ Roehrig, J., Sutter, L., Witsch, N., Rademacher, L., Cabanis, M. ]]></dc:creator>
<dc:date>2026-06-01</dc:date>
<dc:identifier>doi:10.64898/2026.05.28.26354329</dc:identifier>
<dc:title><![CDATA[Opioid crisis in Germany? Insights from a cross-sectional nationwide survey within the German drug scene.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.27.26354253v1?rss=1">
<title>
<![CDATA[
Polysubstance Injection and Smoking Trajectories of Unregulated Drug Use in the San Diego-Tijuana Border Region: A Latent Transition Analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.27.26354253v1?rss=1
</link>
<description><![CDATA[
Background and AimsThe North American overdose crisis is increasingly characterized by complex polysubstance use alongside a transition from injecting to smoking unregulated opioids. However, transitions involving multiple substances remain understudied. We characterized longitudinal transitions in the route of administration and frequency of heroin, fentanyl, and methamphetamine use and examined whether these transitions differed by multilevel factors hypothesized to influence patterns of polysubstance use and routes of administration over time.

DesignPeople who inject drugs (PWID) enrolled in a cohort study completed baseline surveys (October 2020-2021) and three biannual follow-up visits (through April 2023).

SettingSan Diego, California, and Tijuana, Baja California.

ParticipantsAmong 612 PWID, median age was 43 years; most were male (74%), Hispanic, Latino, or Mexican (72%), and San Diego residents (67%).

MeasurementsBased on past six-month substance use behaviors reported at each visit, we categorized participants according to six indicators over time: low- (< weekly) and high-frequency ([&ge;] weekly) smoking and injecting of heroin, fentanyl, and methamphetamine. We then used latent transition analysis (LTA) to identify distinct subgroups of participants with respect to these indicators at baseline and examine transitions between them over 18 months. We fit models with 2-5 subgroups, selecting the final model based on fit and interpretability and used multiple-groups LTA to examine differences in subgroup transitions by multilevel factors.

FindingsWe identified four subgroups: Subgroup 1 ("Heroin-Methamphetamine Polyroute"), characterized by high-frequency heroin and methamphetamine smoking and injection, included 22% of participants at baseline but 0% at 18 months. Subgroup 2 ("Methamphetamine-dominant Smoking"), characterized by high-frequency methamphetamine smoking, accounted for 14% of participants at baseline and 18 months. Subgroup 3 ("Fentanyl-Methamphetamine Smoking"), characterized by high-frequency fentanyl and methamphetamine smoking, included 4% of participants at baseline and 21% at 18 months. Subgroup 4 ("Heroin-dominant Injecting"), characterized by high-frequency heroin injection, included 61% of participants at baseline and 65% at 18 months. Participants in Subgroup 1 primarily transitioned to Subgroups 3 and 4 over time. Larger increases in Subgroup 3 prevalence occurred for participants who, at baseline, experienced homelessness, resided in San Diego (vs. Tijuana), received syringes from a syringe services program, and overdosed in the past six months.

ConclusionsPWID in this region increasingly transitioned from high-frequency heroin and methamphetamine injection toward fentanyl and methamphetamine smoking, likely reflecting shifts in drug availability. Results highlight the need for multilevel interventions that address health harms resulting from polysubstance smoking alongside continued injection.
]]></description>
<dc:creator><![CDATA[ Eger, W. H., Bazzi, A. R., Crable, E. L., Abramovitz, D., Harvey-Vera, A., Vera, C. F., Rangel, M. G., Friedman, J. R., Pitpitan, E. V., Patterson, T. L., Strathdee, S. A., Pines, H. A. ]]></dc:creator>
<dc:date>2026-05-29</dc:date>
<dc:identifier>doi:10.64898/2026.05.27.26354253</dc:identifier>
<dc:title><![CDATA[Polysubstance Injection and Smoking Trajectories of Unregulated Drug Use in the San Diego-Tijuana Border Region: A Latent Transition Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.26.26354113v1?rss=1">
<title>
<![CDATA[
High-resolution Orbitofrontal Cortex Morphometry and Cannabis Use Disorder Severity in High-risk Emerging Adults: A Preliminary Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.26.26354113v1?rss=1
</link>
<description><![CDATA[
BackgroundCannabis use is highly prevalent among emerging adults (18-25 years), a developmental period marked by ongoing neurodevelopment and heightened risk for cannabis use disorder (CUD). Structural alterations in the orbitofrontal cortex (OFC) and medial prefrontal/anterior cingulate cortex (mPFC/ACC) have been linked to cannabis use, though findings remain inconsistent in directionality. To address this, we examined cortical thickness and surface area of the OFC and mPFC/ACC subregions using the high-resolution Glasser atlas, allowing for more granular characterization of associations with CUD severity.

MethodOne hundred eleven emerging adults (41% male, aged=20.6{+/-}1.1 years) reporting significant alcohol and/or cannabis use completed clinical assessments and structural MRI. The OFC and mPFC/ACC were segmented into seven and six subregions per hemisphere, respectively. Multiple linear regressions tested associations between cortical thickness or surface area and DSM-5 CUD symptom count, controlling for alcohol use and intracranial volume. Subregions surviving false discovery rate correction were examined in relation to depression, trauma-related symptoms, impulsivity, and cannabis use motives.

ResultsGreater CUD severity was associated with lower cortical surface area and greater cortical thickness in OFC and mPFC/ACC subregions. Lower OFC surface area was correlated with coping- and enhancement-related cannabis use motives. Lower mPFC/ACC surface area and greater thickness were associated with more severe depression, trauma-related symptoms, and impulsivity.

ConclusionIn high-risk emerging adults, greater CUD symptom burden is associated with lower surface area and greater thickness in OFC and mPFC/ACC subregions. Using the high-resolution Glasser atlas, these findings provide a more precise characterization of structural correlates of CUD and highlight potential neurobiological markers linked to affective and motivational processes underlying cannabis use.
]]></description>
<dc:creator><![CDATA[ Hargreaves, T. L., McIntyre-Wood, C., Elsayed, M., Vandehei, E., Belisario, K. L., Lee, L., Blakely, A., Halladay, J. L., Amlung, M., Sweet, L. H., MacKillop, J. ]]></dc:creator>
<dc:date>2026-05-27</dc:date>
<dc:identifier>doi:10.64898/2026.05.26.26354113</dc:identifier>
<dc:title><![CDATA[High-resolution Orbitofrontal Cortex Morphometry and Cannabis Use Disorder Severity in High-risk Emerging Adults: A Preliminary Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.20.26353682v1?rss=1">
<title>
<![CDATA[
The emotional impact of gambling-related advertising: an experimental functional Near-Infrared Spectroscopy study protocol 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.20.26353682v1?rss=1
</link>
<description><![CDATA[
BackgroundThe proliferation of gambling advertising has intensified concerns regarding its influence on vulnerable populations, yet the neural mechanisms underlying cue-reactivity to these stimuli remain underexplored in ecologically valid settings. This study protocol proposes a novel methodological framework to investigate prefrontal cortical responses to gambling advertisements in individuals with varying degrees of gambling experience.

Materials and methodsThis cross-sectional study will recruit 44 participants, divided into a clinical group (individuals with high-frequency gambling or gambling disorder) and a matched control group. Neural activity will be recorded using fNIRS while participants view gambling-related, neutral, violent, and sexual stimuli. Secondary measures include validated scales for gambling severity (SOGS), impulsivity, sensation seeking, and alexithymia. Data analysis will primarily utilize inter-subject correlation (ISC) to quantify neural synchronization and multiband frequency decomposition to capture dynamic affective processing. Advanced preprocessing, including short-channel regression, will be applied to ensure signal robustness.

DiscussionBy combining portable neuroimaging with a data-driven ISC approach, this study aims to identify objective neural markers of gambling vulnerability. The findings will provide novel insights into the idiosyncratic processing of commercial stimuli, potentially informing public health policies and the development of more effective evidence-based regulations for gambling marketing.
]]></description>
<dc:creator><![CDATA[ Daniel, L.-I., Ros-Leon, A., Molina-Rodriguez, S., Pellicer-Porcar, O., Cabrera-Perona, V., Ibanez-Ballesteros, J. ]]></dc:creator>
<dc:date>2026-05-27</dc:date>
<dc:identifier>doi:10.64898/2026.05.20.26353682</dc:identifier>
<dc:title><![CDATA[The emotional impact of gambling-related advertising: an experimental functional Near-Infrared Spectroscopy study protocol]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.23.26353953v1?rss=1">
<title>
<![CDATA[
Global Burden Of Problematic Internet Use: An Umbrella Review and Metanalysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.23.26353953v1?rss=1
</link>
<description><![CDATA[
ImportanceProblematic use of the internet (PUI) behaviors, including problematic gaming, social media use, smartphone use, and general internet use, have been increasingly studied worldwide. So far it is unclear what the global prevalence of PUI is.

ObjectiveTo critically appraise existing systematic reviews and meta-analyses on the prevalence of PUI behaviors and generate aggregated global prevalence estimates across different manifestations and definitions.

Data SourcesMEDLINE (Ovid), Embase (Ovid), Scopus, Web of Science, CINAHL, and the Cochrane Review Library were searched for relevant articles from database inception to the most recent available search prior to manuscript preparation. Searches targeted systematic reviews and meta-analyses reporting prevalence for PUI-related behaviors.

Study SelectionSystematic reviews and meta-analyses of observational studies reporting prevalence estimates for problematic gaming, problematic internet use, problematic smartphone use, problematic social media use, or sexting were included. Scoping reviews were retained for descriptive synthesis only.

Data Extraction and SynthesisAn umbrella review methodology was used. Data extraction and methodological appraisal were conducted using AMSTAR-2 to assess the quality of included systematic reviews up to February 2026. Primary studies included in each review were extracted and pooled using random-effects meta-analysis. Analyses were conducted to estimate pooled prevalence with 95% confidence intervals (CIs) and heterogeneity across non-overlapping primary studies. Small-study effects were examined.

Main Outcomes and MeasuresGlobal pooled prevalence estimates for PUI behaviors, including problematic gaming, problematic internet use, problematic smartphone use, problematic social media use, and sexting.

ResultsEleven reviews (10 systematic reviews and 1 scoping review) met inclusion criteria, representing data from 3 145 428 individuals, of whom 3 030 023 were included in pooled prevalence analyses. Across regions, pooled prevalence estimates were 6% (95% CI, 5%-7%) for problematic gaming, 16% (95% CI, 15%-17%) for problematic internet use, 32% (95% CI, 28%-35%) for problematic smartphone use, and 23% (95% CI, 19%-28%) for problematic social media use. Substantial heterogeneity (I2 > 99%) was observed across primary studies, reflecting variation in study methodologies, sampled populations, and definitions of PUI behaviors.

Conclusions and RelevancePUI behaviors appear to affect a substantial proportion of the global population. However, methodological concerns were common, with 9 of 10 systematic reviews rated as having low or critically low confidence according to AMSTAR-2. Evidence remains concentrated in East Asia and Europe, and many reviews combine heterogeneous populations and sampling strategies. Additional high-quality epidemiological research, including underrepresented regions is needed to refine prevalence estimates, clarify risk factors, and support the development of standardized criteria for PUI behaviors.

Key PointsO_ST_ABSQuestionC_ST_ABSWhat is the global prevalence of problematic use of the internet (PUI) behaviors across major subtypes, based on an umbrella review of existing reviews and a meta-analysis of nonoverlapping primary studies?

FindingsIn this umbrella review of 11 reviews and random-effects meta-analysis of 753 nonoverlapping primary studies including 3 030 023 individuals, pooled prevalence estimates were 6% for problematic gaming, 16% for problematic internet use, 32% for problematic smartphone use, and 23% for problematic social media use. Findings indicated substantial between-study heterogeneity, and most included systematic reviews were rated low or critically low in methodological quality.

MeaningThese findings suggest that PUI behaviors affect a substantial proportion of the global population, but more methodologically rigorous and geographically representative epidemiological research is needed to generate more precise and comparable prevalence estimates across clinical and population samples.
]]></description>
<dc:creator><![CDATA[ Schwarze-Taufiq, T., Weber, S., Larrain, B., Gatica-Bahamonde, G., Corazza, O., Neicun, J., Stein, D. J., Ioannidis, K., Demetrovics, Z., Chamberlain, S. R., Carmi, L., Zohar, J., Rumpf, H.-J., Hall, N., Menchon, J. M., Sales, C., Montag, C., Lindenberg, K., Susi, M., Huizink, A., Potenza, M. N., Pallanti, S., Morgan, N., Moreno, C., Purper-Ouakil, D., Brand, M., Yucel, M., Czako, A., Walitza, S., Burkauskas, J., Felvinczi, K., Smith, M., Wellsted, D., Jones, J., Dias, T. S., Foster, S., Mohler-Kuo, M., Neumann, I., Fongaro, E., Fally, S., Oliveira, H., Abregu-Crespo, R., Sepulveda-Palomo, M.,  ]]></dc:creator>
<dc:date>2026-05-25</dc:date>
<dc:identifier>doi:10.64898/2026.05.23.26353953</dc:identifier>
<dc:title><![CDATA[Global Burden Of Problematic Internet Use: An Umbrella Review and Metanalysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.15.26351052v1?rss=1">
<title>
<![CDATA[
A genome-wide association study of problematic sexual behaviour: genetic overlap with psychiatric, behavioural and personality phenotypes 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.15.26351052v1?rss=1
</link>
<description><![CDATA[
Problematic Sexual Behaviour (PSB) is defined as difficult to control recurrent sexual behaviours that continue despite adverse consequences, leading to social and functional impairment. There is debate whether PSB is a disorder of compulsion or addiction; PSB often co-occurs with neuropsychiatric disorders, but further elucidation regarding underlying biology is required. A deficiency in reward neurotransmitter systems (reward deficiency syndrome: RDS) may underlie a shared vulnerability to addiction.

We conducted the first case-control genome wide association study (GWAS) of PSB in patients (n=448), and comparison participants with (n=196) and without PSB (n=1488). We used polygenic risk scores (PRS) to test genetic overlap with related psychiatric, behavioural and personality phenotypes. Three models were used: 1) All-PSB (patient + comparison) vs. controls, 2) Patient-PSB vs controls, and 3) RDS (yes/no).

Results suggested genetic overlap of PSB with psychiatric conditions, with PRS for major depression, substance use, and others predicting PSB status. PRS for related behavioural phenotypes (e.g., externalizing, age at first sex, number of lifetime sexual partners) and personality traits also predicted PSB. The patient model showed stronger associations than the All-PSB model, and RDS had both shared and distinct genetics with PSB. As expected with the sample size, only suggestive hits were observed with single variant and gene-based tests.

PSB may share genetic mechanisms with various conditions. Further research in larger cohorts is needed to better understand the underlying genetics and environmental factors involved, and to improve diagnostic classification, intervention and treatment prospects.
]]></description>
<dc:creator><![CDATA[ Foo, J. C., Jiang, S., Ilnytskyy, Y., Li, D., Hu, X., Arnau, R., Isenberg, R., Green, B., Kovalchuk, I., Frank, J., Lodhi, R., Behavioral Addictions Studies and Insights Consortium,, Streit, F., Carnes, P. J., Aitchison, K. J. ]]></dc:creator>
<dc:date>2026-05-20</dc:date>
<dc:identifier>doi:10.64898/2026.05.15.26351052</dc:identifier>
<dc:title><![CDATA[A genome-wide association study of problematic sexual behaviour: genetic overlap with psychiatric, behavioural and personality phenotypes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.15.26353305v1?rss=1">
<title>
<![CDATA[
Single-nucleus RNA sequencing identifies transcriptomic signatures of alcohol use disorder in the human ventral tegmental area 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.15.26353305v1?rss=1
</link>
<description><![CDATA[
BackgroundAlcohol use disorder (AUD) is associated with altered gene expression across diverse cell types in reward-related brain regions, including the ventral tegmental area (VTA), which is rich in dopaminergic neurons. The VTA plays a central role in reward processing, learning, and memory; however, cell type-specific gene expression changes within the VTA remain uncharacterized.

MethodsWe applied single-nucleus RNA sequencing (snRNA-seq) to profile transcriptomic alterations associated with AUD in the VTA. Postmortem VTA samples from four individuals of European ancestry [two with AUD (one male, one female) and two matched controls (one male, one female)] were analyzed using the 10X Genomics Chromium Fixed RNA Profiling protocol. Differentially expressed genes (DEGs) were identified using Seurat, and enriched KEGG pathways was assessed by gene set enrichment analysis.

ResultsNuclei were classified into six major cell types: astrocytes, endothelial cells, mature neurons, microglia, oligodendrocytes, and oligodendrocyte precursor cells (OPCs). At thresholds of P < 0.05 and |fold change| > 2.0, we identified 547 DEGs in astrocytes, 727 DEGs in endothelial cells, 715 DEGs in mature neurons, 421 DEGs in microglia, 263 DEGs in oligodendrocytes, and 432 DEGs in OPCs. DEGs across VTA cell types were enriched for pathways related to mitochondrial function, neurodegeneration, and synaptic signaling. Notably, DEGs in mature neurons were enriched for addiction-related pathways. Further subdivision of mature neurons into dopaminergic, GABAergic, glutamatergic, and unclassified subtypes revealed 526, 930, 896, and 569 DEGs, respectively. Neuronal DEGs indicate a convergence on mitochondrial/oxidative phosphorylation and neurodegeneration-related pathways across subtypes, whereas addiction- and synapse-related pathways show dopaminergic neuron-specific enrichment.

ConclusionsThis study provides the first cell type-resolved transcriptomic profiling of the human VTA, revealing AUD-associated gene expression alterations across neuronal, glial, and endothelial cells. The observed cell type-specific changes in synaptic plasticity and addiction-related genes offer new insights into molecular mechanisms underlying AUD pathophysiology.
]]></description>
<dc:creator><![CDATA[ Patra, S., Koo, J. S., Parihar, A. S., Zhang, C., Zhang, H. ]]></dc:creator>
<dc:date>2026-05-19</dc:date>
<dc:identifier>doi:10.64898/2026.05.15.26353305</dc:identifier>
<dc:title><![CDATA[Single-nucleus RNA sequencing identifies transcriptomic signatures of alcohol use disorder in the human ventral tegmental area]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.11.26352941v1?rss=1">
<title>
<![CDATA[
Characteristics and Circumstances of US Overdose Deaths Identified as Heat-Related 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.11.26352941v1?rss=1
</link>
<description><![CDATA[
ObjectivesTo examine the extent to which heat-related causes of death are recorded in fatal drug overdoses, how these patterns vary across states and over time, and how overdose characteristics differ between deaths with, versus without, heat involvement recorded.

MethodsDeath certificate data for all drug overdose deaths in US residents from 2001 to 2024 (from the National Center for Health Statistics) were analyzed to identify whether a heat-related cause of death was also listed on the death certificate. Joinpoint regression, descriptive statistics, and nonparametric tests were used to examine temporal trends and compare overdose deaths with versus without recorded heat involvement.

ResultsIn 2001, fewer than 10 drug overdose deaths with recorded heat involvement were identified, but this number increased to 558 in 2024. From 2013 to 2024, mortality rates increased significantly, with an estimated annual percent change of 30.1 (95% Confidence Interval, 26.5-47.1). The highest mortality rates and numbers of deaths were observed in residents of Arizona and Nevada. American Indian/Alaska Native, Mexican-heritage, and foreign-born populations accounted for larger shares of overdose deaths with, compared to without, heat involvement recorded. A street or highway was more frequently identified as the place of injury in overdose deaths with (18.9%), versus without (2.2%) heat involvement reported. Psychostimulants such as methamphetamine were involved in 85.9% of overdose deaths with, compared to 28.9% without, recorded heat involvement.

ConclusionsAlthough representing only a fraction of all overdose deaths, fatal overdoses involving heat exposure have increased markedly over time and disproportionately impact certain states and demographic groups.
]]></description>
<dc:creator><![CDATA[ Cano, M., Mun, C. J., Sweeney, K., Daniulaityte, R. ]]></dc:creator>
<dc:date>2026-05-14</dc:date>
<dc:identifier>doi:10.64898/2026.05.11.26352941</dc:identifier>
<dc:title><![CDATA[Characteristics and Circumstances of US Overdose Deaths Identified as Heat-Related]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.05.08.26352752v1?rss=1">
<title>
<![CDATA[
Racial Disparities in Opioid Overdoses: A Comprehensive Claims-Based Analysis, 2020-2024 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352752v1?rss=1
</link>
<description><![CDATA[
PurposeOpioid overdose deaths disproportionately affect racial and ethnic minority populations in the United States, yet claims-based evidence characterizing the multi-dimensional structure of these disparities across incidence, treatment access, costs, and insurance coverage remains limited.

MethodsWe conducted a retrospective cross-sectional and longitudinal cohort analysis using the HealthVerity Launch Sample, a large administrative claims database. The study population comprised 3,675,823 patients across 5 racial groups enrolled between 2020 and 2024. Eight primary analyses were conducted, including age-sex standardized overdose rates, temporal disparity trends, medication-assisted treatment (MAT) receipt, naloxone access, pharmacy costs, insurance payer type, care setting, and multivariable logistic regression for overdose risk.

ResultsBlack patients had the highest age-sex standardized overdose rate (363.4 per 100,000; rate ratio [RR] = 1.27 vs. White), and those with opioid use disorder (OUD) received MAT at a rate 35% lower than White patients (19.8% vs. 30.7%; RR = 0.645), driven primarily by a buprenorphine access deficit. AIAN patients demonstrated consistent multi-dimensional disadvantage across naloxone access, MAT engagement, and pharmacy costs. After adjustment for payer type, age, and sex, all non-White groups showed lower adjusted odds of overdose than White patients (Black OR = 0.87; AIAN OR = 0.25), with Medicaid enrollment carrying 7.06 times the overdose odds of commercial insurance.

ConclusionInsurance type is the dominant predictor of overdose risk, and the disproportionate Medicaid enrollment of Black patients is both a consequence of structural disadvantage and access disparities. Targeted interventions such as buprenorphine expansion in Medicaid and enhanced naloxone distribution are recommended.
]]></description>
<dc:creator><![CDATA[ Pandey, A. ]]></dc:creator>
<dc:date>2026-05-12</dc:date>
<dc:identifier>doi:10.64898/2026.05.08.26352752</dc:identifier>
<dc:title><![CDATA[Racial Disparities in Opioid Overdoses: A Comprehensive Claims-Based Analysis, 2020-2024]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.28.26351962v1?rss=1">
<title>
<![CDATA[
A reliability-screened thalamocortical control-network phenotype tracks cocaine-use history in cocaine use disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.28.26351962v1?rss=1
</link>
<description><![CDATA[
BackgroundA central goal in psychiatry is to move from symptom-defined diagnoses toward biologically interpretable and reliable phenotypes. In cocaine use disorder (CUD), many resting-state abnormalities have been reported, but few circuit-level findings have been explicitly screened for reliability. We tested whether prespecified thalamocortical features yield a reproducible phenotype in CUD and whether that phenotype reflects diagnosis, recent cocaine use, or longer-term illness history.

MethodsDiscovery analyses used resting-state data from 105 participants (46 healthy controls, 59 CUD). From a 13-region thalamocortical circuit, we derived an HC-trained LEiDA state model, generated 11 prespecified features, and advanced only those meeting split-half reliability criteria (ICC[3,1] [&ge;]0.40). A separate paired TMS sample (n=44) was used for extension analyses.

ResultsFive features survived reliability screening. Within CUD, longer duration since beginning cocaine use was associated with greater occupancy of a control-like state (standardized {beta}=0.37, q=0.005) and stronger whole-thalamus connectivity with control frontoparietal cortex (standardized {beta}=0.30, q=0.018). Neither days since last use nor CUD vs. healthy diagnosis were associated with any reliable feature after correction. Joint-history models indicated that the signal was better explained by longer-term use history than by recent use. Localization analyses indicated the connectivity effect was concentrated in dorsal thalamic regions. TMS-interaction and effective-connectivity follow-ups were null.

ConclusionsReliability screening identified a thalamocortical control-network phenotype in CUD that tracks longer cocaine-use history rather than diagnosis or recent use. More broadly, this workflow offers a practical framework for screening candidate circuit-level psychiatric phenotypes for reliability.
]]></description>
<dc:creator><![CDATA[ Edelman, B. B., Skolnick, J. ]]></dc:creator>
<dc:date>2026-04-29</dc:date>
<dc:identifier>doi:10.64898/2026.04.28.26351962</dc:identifier>
<dc:title><![CDATA[A reliability-screened thalamocortical control-network phenotype tracks cocaine-use history in cocaine use disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.25.26350029v1?rss=1">
<title>
<![CDATA[
Family-supervised disulfiram as a culturally grounded model for alcohol use disorder treatment in Sri Lanka: a pilot randomized controlled trial 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.25.26350029v1?rss=1
</link>
<description><![CDATA[
ObjectivesTo evaluate the effectiveness and cultural feasibility of family-supervised disulfiram as a first-line treatment for alcohol use disorder (AUD) in Sri Lanka, and to compare its clinical outcomes with standard therapy delivered at a tertiary psychiatric unit.

DesignSingle-blind Randomized Controlled Trial known as ETAT-RCT (Efficacy of Two Alcohol Treatments) was conducted under routine clinical setup with three parallel groups: family-supervised disulfiram, locally developed psychosocial intervention, and routine treatment. Allocation was independently concealed; assessors were blinded. Analyses followed an intention-to-treat approach using repeated-measures ANOVA (group x time). This paper reports the disulfiram (test) versus routine treatment (control) comparison; the psychosocial intervention will be reported separately.

SettingUniversity Psychiatry Unit, National Hospital of Sri Lanka, Colombo (UPU, NHSLC).

ParticipantsPatients aged [&ge;]14 years with AUD presenting to the unit were recruited consecutively without inducements. Planned allocation ratio was 1:1:1 with 31 participants per arm; key exclusions were lifetime psychotic disorder and current contraindication to disulfiram.

RandomisationParticipants were randomised into each treatment arm using an independent concealed paper-based allocation system.

Intervention(1) family-supervised disulfiram, with psychoeducation/support only - DT arm, (2) a locally developed denormalization focused psychosocial programme - PT arm, and (3) standard therapy (motivational/cognitive/behavioural input; naltrexone permitted; no disulfiram/denormalisation) - ST arm.

Outcome measuresPrimary outcome was Alcohol Use Disorders Identification Test (AUDIT) score at 12 months. Key secondary outcomes were past 30 day alcohol use via Timeline Follow-Back (TLFB); alcohol biomarkers [ALT (alanine aminotransferase), {gamma}-GT (gamma-glutamyl transferase), MCV (mean corpuscular volume)]; locally developed measures of addiction-relevant cognitive, affective, behavioural factors [AARSU (Attitude Assessment Related to Substance Use), BARSU (Behaviour Assessment Related to Substance Use)]; and Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF). Outcomes were assessed at baseline, 6, and 12 months.

ResultsParticipants in DT (n=33) and ST (n=38) were comparable at baseline. Both groups showed clinically and statistically significant improvement in AUDIT scores over 12 months (DT: F=39.90, p<0.001; ST: F=49.90, p<0.001), with no groupxtime interaction (F<0.001, p=0.98). Biomarkers and AARSU, and BARSU and Q-LES-Q-SF to a lesser degree, mirrored the AUDIT pattern. TLFB did not change significantly over time in either arm (p>0.05). In moderator analyses, improvement in AUDIT was not moderated by baseline motivation (F=0.20, p=0.89) but was moderated by baseline AUD severity (F=7.70, p=0.007). No serious adverse events were attributed to disulfiram. Adherence to supervised dosing was generally high during periods of supervision but intermittent overall.

ConclusionsIn this pilot RCT, family-supervised disulfiram achieved 12-month outcomes comparable to standard therapy in a tertiary Sri Lankan setting. Improvements were independent of baseline motivation and varied by baseline AUD severity. These findings may support family-supervised disulfiram as a culturally feasible first-line option in Sri Lanka; larger, adequately powered multicentre trials are warranted to confirm effectiveness and scalability.

Trial registrationSLCTR/2014/021

Strengths and limitations of this studyO_LIThis pragmatic randomised controlled trial demonstrates an improved real world applicability and validity as it was conducted in an unmodified public-sector psychiatric setting.
C_LIO_LIStrong generalisability of the study with similar health systems due to broad eligibility criteria of patients warranted the inclusion of regular and general patient cohort with alcohol use disorders, strengthening generalisability within similar health systems.
C_LIO_LIInterventions were carried out without additional staff or patient monitoring reflecting routine clinical practice.
C_LIO_LIComprehensive assessment beyond abstinence alone with multidimensional outcomes such as alcohol related harm, biomarkers, cognitive behavioural change and quality of life.
C_LIO_LIMinor potential in performance bias due to the nature of intervention where blinding study subjects and clinicians is not feasible.
C_LIO_LISampling bias towards males and variability within the ST arm can affect the generalisability.
C_LI
]]></description>
<dc:creator><![CDATA[ Rajasuriya, M., Chulasiri, P., Ratnayake, P., Plevin, D. ]]></dc:creator>
<dc:date>2026-04-27</dc:date>
<dc:identifier>doi:10.64898/2026.04.25.26350029</dc:identifier>
<dc:title><![CDATA[Family-supervised disulfiram as a culturally grounded model for alcohol use disorder treatment in Sri Lanka: a pilot randomized controlled trial]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.17.26351044v1?rss=1">
<title>
<![CDATA[
Exploring the Relationship Between Non-Suicidal Self-Injury and Problematic Sexual Behaviour 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.17.26351044v1?rss=1
</link>
<description><![CDATA[
ObjectivesNon-suicidal self-injury (NSSI) and self-harming sexual behaviours share functional and behavioural overlaps. However, the relationship between NSSI and problematic sexual behaviour (PSB) remains underexplored. This study aimed to investigate the association between NSSI and PSB in two cohorts - a non-clinical university cohort and a clinical PSB patient cohort.

MethodsData were collected from 2,189 university participants and 477 clinical PSB patients. NSSI was assessed via self-report, and PSB was measured with the Sexual Addiction Screening Test-Revised (SAST-R) Core. The four core addictive dimensions of PSB: relationship disturbance, loss of control, preoccupation, and affect disturbance, were also evaluated. Logistic regression analyses were conducted to examine the association between PSB (presence/absence and severity) and NSSI, looking at effects of gender and contributions of addictive dimensions of PSB.

ResultsRates of NSSI were similar in the university (7.1%) and patient (5.7%) cohorts; stratified by gender, a higher proportion of women PSB patients had NSSI compared to in the university cohort (29.3% vs 9.3%). In the university group, who had milder PSB than patients, PSB was associated with NSSI (OR=2.11, p<0.001); a significant gender by PSB interaction was found showing that women with PSB were over four times more likely to have NSSI than men without PSB (OR=4.44, p=0.037). In contrast, PSB severity was not associated with NSSI in PSB patients (OR=1.10, p=0.25). Associations of the addictive dimensions of PSB with NSSI were observed only in the subgroup of university women, in the  preoccupation dimension (p<0.001).

ConclusionsOur findings highlight gender-specific patterns in the association between PSB and NSSI, suggesting the need for further research and possibly targeted prevention and intervention strategies in women.
]]></description>
<dc:creator><![CDATA[ Jiang, S., Foo, J. C., Roper, L., Yang, E., Green, B., Arnau, R., Behavioral Addictions Studies and Insights Consortium,, Lodhi, R. J., Isenberg, R., Wishart, D. S., Fujiwara, E., Carnes, P. J., Aitchison, K. J. ]]></dc:creator>
<dc:date>2026-04-25</dc:date>
<dc:identifier>doi:10.64898/2026.04.17.26351044</dc:identifier>
<dc:title><![CDATA[Exploring the Relationship Between Non-Suicidal Self-Injury and Problematic Sexual Behaviour]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.23.26351366v1?rss=1">
<title>
<![CDATA[
Regular cannabis use is associated with altered neural and behavioural responses during anticipation and feedback of monetary reward and loss 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.23.26351366v1?rss=1
</link>
<description><![CDATA[
Regular cannabis use has been associated with alterations in reward-related neural processes, yet findings remain inconsistent and the relationship between neural activity and behavioural performance is not fully understood. The present study aimed to characterise neural and behavioural correlates of reward processing in regular cannabis users (CU) compared with matched non-users (NU) using the Monetary Incentive Delay Task (MIDT).

Firstly, we assessed behavioural performance through reaction times, accuracy and monetary earnings to determine whether potential neural alterations were reflected in task performance. Secondly, focusing on reward-related brain regions, we examined group differences in BOLD functional MRI activity during anticipation and outcome phases separately for monetary win and loss conditions. Finally, we explored the association between behavioural performance and neural activation. Our findings indicate that regular cannabis use is associated with altered engagement of key nodes within the mesocorticolimbic circuit during both anticipatory and outcome phases of reward processing, accompanied by impaired behavioural performance. Particularly, compared with NU, CU showed (I) lower striatal activity during anticipation of monetary win and higher ventral striatum and frontal pole activity during anticipation of monetary loss; (II) greater VTA activation during outcome of successful monetary win and loss avoidance and lower frontal pole activity during outcome of unsuccessful loss avoidance; (III) impaired behavioural performance, reflected in lower monetary rewards and a trend towards slower reaction times and reduced accuracy; (IV) disrupted brain-behaviour coupling.

Results from this study may help inform future research on the neurobiological mechanisms underlying changes in reward function and the resultant behavioural consequences of cannabis use.
]]></description>
<dc:creator><![CDATA[ Lombardi, G., Blest-Hopley, G., Tarantini, M. M., O'Neill, A., Wilson, R., O'Daly, O., Giampietro, V., Bhattacharyya, S. ]]></dc:creator>
<dc:date>2026-04-24</dc:date>
<dc:identifier>doi:10.64898/2026.04.23.26351366</dc:identifier>
<dc:title><![CDATA[Regular cannabis use is associated with altered neural and behavioural responses during anticipation and feedback of monetary reward and loss]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.17.26351089v1?rss=1">
<title>
<![CDATA[
Indirect Genetic Effects on Alcohol Use Disorder and Nicotine Dependence 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.17.26351089v1?rss=1
</link>
<description><![CDATA[
Substance use disorders run in families, yet the mechanisms underlying intergenerational transmission remain unclear. We investigated indirect genetic effects, pathways through which parental genotypes influence offspring phenotypes via the family environment, for alcohol use disorder (AUD), nicotine dependence (ND), and related quantitative outcomes, and aimed to identify family environmental factors through which such effects may operate. Using transmitted and non-transmitted polygenic scores (PGS) constructed for problematic alcohol use, tobacco use disorder, and general addiction liability, we analyzed 5972 European-ancestry adult offspring with at least one genotyped parent from the population-based Lifelines cohort (Netherlands). Offspring outcomes included lifetime DSM-5 AUD diagnosis, AUD symptom count, maximum drinks in 24 hours, Fagerstrom Test for Nicotine Dependence score, and cigarettes per day. AUD findings were meta-analyzed with data from the Brisbane Longitudinal Twin Study (N = 1368; Australia). We also examined parent-of-origin effects and mediation by parental substance use and socioeconomic status using structural equation modeling. Transmitted PGS robustly predicted all AUD and ND outcomes ({beta} = 0.07-0.16; OR = 1.20 for AUD diagnosis). Non-transmitted PGS, indexing indirect genetic effects, were negligible for all clinical syndrome outcomes. The only significant indirect genetic effect was on cigarettes per day ({beta} = 0.03, p = 0.01), mediated by parental smoking behavior but not socioeconomic status. These findings indicate that intergenerational transmission of risk for AUD and ND is driven primarily by direct genetic effects, with modest indirect genetic effects on smoking quantity. Larger samples and cross-trait analyses are needed to further elucidate these mechanisms.
]]></description>
<dc:creator><![CDATA[ Luo, M., Trindade Pons, V., Zakharin, M., Pingault, J.-B., Gillespie, N. A., van Loo, H. M. ]]></dc:creator>
<dc:date>2026-04-19</dc:date>
<dc:identifier>doi:10.64898/2026.04.17.26351089</dc:identifier>
<dc:title><![CDATA[Indirect Genetic Effects on Alcohol Use Disorder and Nicotine Dependence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.13.26350800v1?rss=1">
<title>
<![CDATA[
Adiposity and inflammation mediate altered metabolic profiles in individuals with opioid use disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.13.26350800v1?rss=1
</link>
<description><![CDATA[
Previous studies have linked opioid use to altered metabolic profiles, but findings have been inconsistent and mechanisms remain unclear. One potential mechanism involves increased adiposity, leading to chronic low-grade inflammation that elevates metabolic risk. Here, we examined metabolic profiles in individuals with opioid use disorder (OUD) and matched non-OUD controls, focusing on the sequential mediating roles of BMI and inflammation. Data from individuals with OUD (n=281) and non-OUD (n=246) were drawn from a natural history screening protocol from the National Institute on Alcohol Abuse and Alcoholism intramural program. Groups were matched on age, sex, race, ethnicity, socioeconomic status, and education via propensity score matching. Metabolic measures included BMI, blood glucose, hemoglobin A1c (HbA1c), and lipid profiles, with lipid imbalance indexed by the atherogenic index of plasma (AIP). Inflammatory markers included C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Individuals with OUD had significantly higher BMI (F1,481=12.9, p<0.001), HbA1c (F1,481=10.5, p=0.001), lower high-density lipoprotein cholesterol (HDL-C; F1,481= 46.2, p< 0.001), higher low-density lipoprotein cholesterol (LDL-C; F1, 481=11.9, p< 0.001), and higher AIP (F1,481=20.7, p< 0.001) compared to non-OUD. Inflammatory markers were also elevated in individuals with OUD, including CRP (F1,481=9.4, p=0.002) and ESR (F1,481=7.4, p= 0.007), and statistically mediated group differences in AIP and HbA1c, respectively. Our results are consistent with prior evidence of metabolic dysfunctions in individuals with OUD and suggest inflammation as a contributing mechanism. Targeting metabolic health and inflammation may offer new avenues for improving long-term health outcomes in OUD.
]]></description>
<dc:creator><![CDATA[ Li, X., Manza, P., Wang, G.-J., Giddens, N., Belcher, A., Schwandt, M., Diazgranados, N., Lynch, K. G., Volkow, N. D., Shi, Z., Wiers, C. E. ]]></dc:creator>
<dc:date>2026-04-18</dc:date>
<dc:identifier>doi:10.64898/2026.04.13.26350800</dc:identifier>
<dc:title><![CDATA[Adiposity and inflammation mediate altered metabolic profiles in individuals with opioid use disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.15.26350988v1?rss=1">
<title>
<![CDATA[
A Machine Learning Based Causal Interface for Time-Varying Environmental Predictors of Substance Use Initiation in the ABCD Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.15.26350988v1?rss=1
</link>
<description><![CDATA[
BackgroundThe Adolescent Brain Cognitive Development (ABCD) Study(R) offers rich longitudinal data on environmental, genetic, and other factors related to substance use initiation. Classical marginal structural models (MSMs) require selecting covariates for propensity models, which is challenging in the presence of hundreds of correlated predictors.

MethodsWe analyzed longitudinal panel data from 11,868 ABCD participants, where each individual contributed repeated observations over time. Interval-level binary outcomes were defined for initiation of alcohol, nicotine, cannabis, and any substance, restricting analyses to participants at risk prior to initiation. All predictors were constructed as lagged variables to preserve temporal ordering. We implemented a two-stage machine learning-based causal framework. First, we performed graph discovery using a Granger-inspired lagged predictive modeling approach, applying elastic-net logistic regression to identify predictive relationships between lagged environmental variables and future initiation outcomes. Robust candidate edges were selected using subject-level bootstrap stability selection. Second, we estimated adjusted effect sizes for stable edges using double machine learning (DML)-style partialling-out with cross-fitting. For each candidate predictor, the treatment was defined as the lagged variable of interest and adjusted for high-dimensional lagged covariates. Cross-fitting with group-based splitting accounted for within-subject dependence, and nuisance functions were estimated using random forest models. Cluster-robust standard errors were used for inference.

ResultsWe identified a set of stable predictors across multiple domains, including sleep patterns, family environment, peer relationships, behavioral traits, and genetic risk. Many predictors were shared across substance outcomes, while some were outcome-specific. Estimated effect sizes were modest, typically ranging from -0.01 to 0.02 per standard deviation increase in the predictor. Both risk-increasing and protective associations were observed. Risk factors included sleep disturbance and behavioral risk indicators, while protective factors included parental monitoring and structured environments.

ConclusionsThis study provides a practical framework for analyzing high-dimensional longitudinal data and identifying time-varying predictors of substance use initiation. The approach combines machine learning for variable selection with causal inference methods for effect estimation. The results highlight both shared and substance-specific risk factors and identify modifiable targets, such as family environment and sleep, that may inform prevention strategies.
]]></description>
<dc:creator><![CDATA[ Wei, M., Yadlapati, L., Peng, Q. ]]></dc:creator>
<dc:date>2026-04-17</dc:date>
<dc:identifier>doi:10.64898/2026.04.15.26350988</dc:identifier>
<dc:title><![CDATA[A Machine Learning Based Causal Interface for Time-Varying Environmental Predictors of Substance Use Initiation in the ABCD Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.14.26350880v1?rss=1">
<title>
<![CDATA[
Stakeholder views on implementing a novel addiction screening and prevention tool in a hospital setting: A qualitative study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.14.26350880v1?rss=1
</link>
<description><![CDATA[
Withdrawal StatementThis version of the manuscript and associated files have been removed owing to the presence of confidential information.
]]></description>
<dc:creator><![CDATA[ Dash, G. F., Balcke, E., Poore, H., Dick, D. ]]></dc:creator>
<dc:date>2026-04-16</dc:date>
<dc:identifier>doi:10.64898/2026.04.14.26350880</dc:identifier>
<dc:title><![CDATA[Stakeholder views on implementing a novel addiction screening and prevention tool in a hospital setting: A qualitative study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.10.26350655v1?rss=1">
<title>
<![CDATA[
Dynamic and Baseline Multi-Task Learning for Predicting Substance Use Initiation in the ABCD Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.10.26350655v1?rss=1
</link>
<description><![CDATA[
BackgroundEarly initiation of substance use is linked to later adverse outcomes, and risk factors come from multiple domains and are shared across substances. In our previous work, traditional time-to-event Cox models identified individual risk factors, but these models are not designed to jointly model multiple outcomes or capture complex non-linear relationships. Multi-task learning (MTL) can leverage shared structure across related outcomes to improve prediction and distinguish common versus substance-specific predictors. However, most MTL studies rely on baseline features and focus on single outcomes, which limits their ability to capture shared risk and temporal changes. Substance use initiation is a time-dependent process that unfolds during development and reflects changing exposures over time. Baseline-only models cannot capture these changes or represent risk dynamics. Discrete-time modeling provides a practical approach by estimating interval-level initiation risk and combining it into cumulative risk at the subject level. By integrating multi-task learning with dynamic modeling, it is possible to share information across outcomes while capturing how risk evolves over time, which may improve prediction performance.

MethodsUsing the Adolescent Brain Cognitive Development (ABCD) Study(R) (release 5.1), we developed two complementary multi-task learning (MTL) frameworks to predict initiation of alcohol, nicotine, cannabis, and any substance use. A baseline MTL model predicted fixedhorizon (48-month) initiation using one record per participant, while a dynamic discrete-time MTL model incorporated longitudinal interval data to model time-varying risk. Both models used multi-domain environmental exposures, core covariates, and polygenic risk scores (PRS). Performance was evaluated on a held-out test set using AUROC, PR-AUC, and calibration metrics, and compared with single-task logistic regression (LR). Feature importance was assessed using permutation importance and compared with Cox proportional hazards models.

ResultsMTL showed comparable or improved performance relative to LR, with larger gains for low-prevalence outcomes (cannabis and nicotine). Incorporating longitudinal information led to consistent improvements across all outcomes. Dynamic models increased AUROC by +0.044 to +0.062 for MTL and +0.050 to +0.084 for LR, indicating that temporal information was the primary driver of performance gains. Feature importance analyses showed modest overlap across methods, with higher agreement between dynamic MTL and Cox models than static MTL. A small set of features, including externalizing behavior, parental monitoring, and developmental factors, were consistently identified across all approaches.

ConclusionsDynamic multi-task learning improves the prediction of substance use initiation by leveraging longitudinal structure and shared information across outcomes. While MTL provides additional gains, incorporating time-varying information is the dominant factor for improving performance. Combining baseline and dynamic frameworks offers a comprehensive strategy for identifying robust risk factors and modeling adolescent substance use initiation.
]]></description>
<dc:creator><![CDATA[ Wei, M., Zhang, H., Peng, Q. ]]></dc:creator>
<dc:date>2026-04-13</dc:date>
<dc:identifier>doi:10.64898/2026.04.10.26350655</dc:identifier>
<dc:title><![CDATA[Dynamic and Baseline Multi-Task Learning for Predicting Substance Use Initiation in the ABCD Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.11.26350657v1?rss=1">
<title>
<![CDATA[
Drug Checking Services in Latin America vs. the United States: Staff Perspectives, Program Characteristics, and Barriers to Implementation 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.11.26350657v1?rss=1
</link>
<description><![CDATA[
BackgroundDrug checking services (DCS) promote drug supply awareness among people who use drugs (PWUD) by detecting adulterants such as fentanyl and xylazine that are associated with overdose morbidity and mortality. However, there is limited research on DCS implementation in Latin America (LA).

MethodsWe conducted a survey of 38 DCS across LA (n=10) and the US (n=28) and compared program characteristics and barriers between these two regions. We also conducted a focus group discussion (FGD) with staff representing six organizations implementing DCS in LA. FGD themes were mapped to constructs quantitatively assessed in the survey.

ResultsCompared to US DCS, LA DCS more frequently reported funding gaps as a major implementation barrier (80% vs. 54%), law enforcement confiscating DCS supplies (38% vs. 11%), as well as offering supervised drug consumption (30% vs. 4%) and mental health/counseling (40% vs. 18%), but less frequently reported that DCS equipment was legal (44% vs. 75%). DCS on the Mexico-US border focused on people who inject drugs and offered syringe services, supervised consumption, and rapid sexually transmitted infection testing. DCS in central Mexico, Colombia, Peru, and Chile primarily provided DCS for the nightlife community (e.g., attendees of concerts/raves). Barriers to DCS implementation cited by FGD discussants included inadequate funding, DCS legal ambiguities, lack of government support, and cartel violence.

ConclusionDCS in LA would benefit from increased funding, government support, and a more permissive legal environment, thereby strengthening harm reduction efforts and improving safety for PWUD.
]]></description>
<dc:creator><![CDATA[ Bird, J. A., Rosen, J. G., Lira, J. A. S., Green, T. C., Park, J. N. N. ]]></dc:creator>
<dc:date>2026-04-13</dc:date>
<dc:identifier>doi:10.64898/2026.04.11.26350657</dc:identifier>
<dc:title><![CDATA[Drug Checking Services in Latin America vs. the United States: Staff Perspectives, Program Characteristics, and Barriers to Implementation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.03.26348150v1?rss=1">
<title>
<![CDATA[
Network and receptor architectures shape brain morphometry in addiction 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.03.26348150v1?rss=1
</link>
<description><![CDATA[
Substance use disorders (SUD) are chronic conditions with devastating effects on brain health, functioning, and survival. In this study, we compared brain morphometry of 2,782 individuals with SUD to 1,951 controls and assessed the topographic overlap of these differences with brain connectivity and receptor architecture. Across SUD, we identified a morphometric signature involving frontal, parietal, temporal and limbic systems that overlapped with cortical hub regions and harbored cortical and subcortical disease epicenters. Findings were highly consistent across six substances and numerous robustness and generalizability analyses. Transdiagnostic comparisons showed high spatial overlap of SUD epicenters with those of schizophrenia and bipolar disorder, suggesting shared network-constrained cortical differences. Finally, multivariate mapping revealed that SUD brain differences aligned with two neurotransmitter axes contrasting cannabinoid-opioid and dopaminergic systems. These findings indicate that addiction-related brain differences are shaped by connectome and neurotransmitter architecture, positioning brain network and neurochemical organization as key principles of SUD-related brain alterations.
]]></description>
<dc:creator><![CDATA[ Georgiadis, F., Milano, B. A., Lariviere, S., Hutchinson, K. E., Calhoun, V., Li, C.-S. R., Momenan, R., Sinha, R., Veltman, D., van Holst, R., Goudriaan, A., Luijten, M., Groefsema, M., Walter, H., Lett, T., Wiers, R., Schmaal, L., Flanagan, J., Porjesz, B., Ipser, J., Boehmer, J., Canessa, N., Salas, R., London, E., Paulus, M., Stein, D., Brooks, S., Reneman, L., Schrantee, A., Filbey, F., Hester, R., Yucel, M., Lorenzetti, V., Solowij, N., Martin-Santos, R., Batalla, A., Cousijn, J., Pomarol-Clotet, E., Garza-Villarreal, E. A., Leyton, M., Stein, E., Crunelle, C. L., Kaag, A. M., Verdejo-Ga ]]></dc:creator>
<dc:date>2026-04-06</dc:date>
<dc:identifier>doi:10.64898/2026.04.03.26348150</dc:identifier>
<dc:title><![CDATA[Network and receptor architectures shape brain morphometry in addiction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.04.01.26349949v1?rss=1">
<title>
<![CDATA[
Chinese College Student Gamers Cohort (CCSGC): Multimodal Longitudinal Insights into Internet Gaming Disorder's Biopsychosocial Mechanisms and Risk Trajectories 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.04.01.26349949v1?rss=1
</link>
<description><![CDATA[
Internet gaming disorder (IGD) presents a significant public health challenge, yet its complex biopsychosocial mechanisms and dynamic risk trajectories remain poorly understood due to a scarcity of comprehensive longitudinal and multimodal cohorts. To address this critical gap, we established the Chinese College Student Gamers Cohort (CCSGC), a prospective, multimodal longitudinal study of 793 first-year undergraduates primarily playing Honor of Kings from 2022 Sept. The CCSGC integrates semi-annual psychosocial questionnaires, annual neuroimaging (EEG/fMRI), and biospecimen collection over multiple years. Baseline data revealed individuals with IGD (n=211) exhibited significantly higher gaming craving, psychological distress (depression, anxiety), impulsivity, and maladaptive motivational features compared to non-IGD gamers (regular players (RP) n=400; casual players (CP) n=182). Longitudinal analyses across four waves indicated bidirectional temporal associations between IGD severity and mental symptoms, and a stabilization of IGD incidence after an initial decrease. Furthermore, specific neurophysiological (e.g., N400 amplitude to game cues) and neuroimaging (e.g., superior parietal activation) markers were identified that correlated with IGD severity and predicted one-year outcomes in gaming disorder or social functioning. The CCSGC provides an invaluable resource for dissecting the heterogeneity, comorbidity, and intricate biopsychosocial mechanisms of IGD, holding significant potential to advance risk prediction, early identification, and targeted intervention strategies.
]]></description>
<dc:creator><![CDATA[ Yuchen, H., Guangdong, Z., Yifan, L., Shitong, X., Qihong, Z., Zifeng, W., Yixuan, S., Wangyue, L., Taoyu, W., Shiqiu, M., Yanhui, L., Tianye, J., Jie, S., Yan, S. ]]></dc:creator>
<dc:date>2026-04-01</dc:date>
<dc:identifier>doi:10.64898/2026.04.01.26349949</dc:identifier>
<dc:title><![CDATA[Chinese College Student Gamers Cohort (CCSGC): Multimodal Longitudinal Insights into Internet Gaming Disorder's Biopsychosocial Mechanisms and Risk Trajectories]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-04-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.03.26.26349460v1?rss=1">
<title>
<![CDATA[
Can Dietary Fibre Intake Reduce the Risk of Mental and Behavioral Disorders Due to Use of Tobacco in Smokers? 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.03.26.26349460v1?rss=1
</link>
<description><![CDATA[
Background and aimsMental and behavioral disorders due to use of tobacco (MBDT) present a critical challenge to global health, yet modifiable lifestyle factors for reducing its risk remain poorly understood. Given that dietary fibre can affect mental health through gut-brain communication, we sought to explore how fibre intake relates to MBDT risks in smokers.

MethodsWe specifically evaluated the link between dietary fibre intake and MBDT within a smoking population. Utilizing the UK Biobank (UKB) database, we performed cross-sectional (N=19,943) and prospective cohort (N=19,885) evaluations applying logistic and Cox proportional hazards models, respectively. To determine potential causality, two-sample Mendelian randomization (MR) was applied, relying on GWAS summary data derived from the IEU Open GWAS Project and FinnGen repositories.

ResultsCross-sectional findings indicated that individuals in the top quartile (Q4) of fibre intake exhibited decreased MBDT risks relative to the bottom quartile (Q1) (OR: 0.32, 95% CI: 0.13-0.79). Over a median observation time of 12.84 years, the prospective evaluation demonstrated a notable inverse correlation (Q4 HR: 0.46, 95% CI: 0.40-0.54). Non-linear modeling via restricted cubic splines uncovered an L-shaped dose-response curve. Furthermore, MR results confirmed a genetically predicted protective causality (IVW OR: 0.68, 95% CI: 0.49-0.95), which remained consistent across sensitivity validations.

ConclusionsAmong smokers, higher dietary fibre intake is robustly associated with a reduced risk of mental and behavioral disorders due to the use of tobacco, offering a modifiable dietary target for public health interventions.
]]></description>
<dc:creator><![CDATA[ Qi, X., Qi, H., li, N., Wang, T., Wang, W., Song, X., Mi, B., Zhang, D. ]]></dc:creator>
<dc:date>2026-03-28</dc:date>
<dc:identifier>doi:10.64898/2026.03.26.26349460</dc:identifier>
<dc:title><![CDATA[Can Dietary Fibre Intake Reduce the Risk of Mental and Behavioral Disorders Due to Use of Tobacco in Smokers?]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-03-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.03.17.26348617v1?rss=1">
<title>
<![CDATA[
Effectiveness of the Smoke Free App for Smoking Cessation -- Results of RAUCHFREI, a Randomised, Double-blind, Controlled, Two-arm, Parallel, Nationwide, Decentralised, Fully Remote Clinical Trial in Germany 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.03.17.26348617v1?rss=1
</link>
<description><![CDATA[
ObjectivesUptake of evidence-based smoking cessation support remains limited. Digital interventions offer the prospect of scalable and highly accessible support. Smoke Free, a digital mobile application using established behaviour change techniques, has shown promise, but no large-scale randomised controlled efficacy trial has yet been conducted. We assessed its effectiveness for smoking cessation.

DesignIn this prospective, randomised, controlled, two-arm, parallel clinical trial with 6-month follow-up, study personnel and patients were blinded.

SettingThe trial was conducted nationwide in Germany, utilising a decentralised, fully remote trial design. Enrolment took place digitally after receiving brief advice from a healthcare professional, following guidelines for primary care.

ParticipantsOut of a volunteer sample of 1850 patients assessed for eligibility, 1466 adult cigarette smokers who had at least moderate cigarette dependence (F17.2, FTCD[&ge;]3) were recruited between August 2023 and February 2024; 84.1% (1233 participants) completed the primary outcome measure.

InterventionsThe intervention group (IG) received the Smoke Free app including behaviour-change missions and gamification elements, while the control group (CG) received a text-only cessation information app. Both groups received brief advice from a healthcare professional.

Main outcome measuresThe prespecified primary outcome was self-reported 7-day point-prevalence abstinence from combustible tobacco at 6 months post-randomisation; secondary outcomes included biochemical validation of abstinence in participants providing a saliva sample (59% of eligible participants).

ResultsSelf-reported abstinence (primary outcome) was significantly higher in the IG compared with the CG (283 [39.3%] vs. 182 [24.4%], OR=2.01, 95% CI 1.60 to 2.50, p<0.0001). The NNT was 6.7 (5.1 to 9.8). The effect was consistent with biochemical validation (OR=1.76, 95% CI 1.27 to 2.44, p<0.0001) and across secondary outcomes and sensitivity analyses. The 6-month follow-up rates for the primary outcome did not differ between groups (IG: 601 [83.5%]; CG: 632 [84.7%]; p=0.52). Eighty-four serious adverse events were reported by 75 participants (IG: 31, 4.3%; CG: 44, 5.9%; p=0.53); none were treatment-related.

ConclusionsThe Smoke Free app is effective for aiding smoking cessation in at least moderately dependent cigarette smokers compared with an informational app when provided as an adjunct to brief advice from a healthcare professional.

Trial registrationThe trial was registered with the German Clinical Trials Register (DRKS00031140).

FundingSmoke Free 23 GmbH (for-profit company).
]]></description>
<dc:creator><![CDATA[ Keller, L., Schraplau, A., Timpel, P., Schönfelder, T., Scheibe, S., Heinrich, R., Bricker, J. B., Brown, J., Naughton, F., Raupach, T., West, R., Pontes da Silva, B., Schmidt-Lucke, C., Crane, D. ]]></dc:creator>
<dc:date>2026-03-19</dc:date>
<dc:identifier>doi:10.64898/2026.03.17.26348617</dc:identifier>
<dc:title><![CDATA[Effectiveness of the Smoke Free App for Smoking Cessation -- Results of RAUCHFREI, a Randomised, Double-blind, Controlled, Two-arm, Parallel, Nationwide, Decentralised, Fully Remote Clinical Trial in Germany]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-03-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.03.16.26348531v1?rss=1">
<title>
<![CDATA[
Preliminary investigation of between-network connectivity and craving during early alcohol abstinence 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.03.16.26348531v1?rss=1
</link>
<description><![CDATA[
BackgroundAlcohol use disorder (AUD) is a chronic condition characterized by compulsive drinking and high relapse risk. Craving in early abstinence is a strong predictor of relapse, yet its underlying neurobiological mechanisms remain unclear. Guided by Menons Triple Network Model (TNM) of psychopathology, this study investigates whether altered connectivity between the salience (SN), default mode (DMN), and central executive (CEN) networks --previously implicated in alcohol-related behaviours -- underlies craving during early abstinence.

MethodsA final cohort of 27 individuals with AUD recruited from an inpatient alcohol withdrawal program completed resting-state fMRI scans on day 1 of withdrawal and 18 days later. Additionally, 17 healthy controls underwent fMRI at two sessions spaced two weeks apart. Craving was assessed in the AUD group at both timepoints using the obsessive thoughts subscale of the Obsessive Compulsive Drinking Scale (OCDS). Functional connectivity between brain networks was computed by referencing each individuals between-network connectivity to normative models derived from large-scale reference data to generate scores reflecting their deviations from normative values.

Proposed analysesPlanned analyses will leverage large-scale lifespan normative models to test associations between patient deviation scores in SN-DMN connectivity and craving during acute withdrawal, along with longitudinal associations during abstinence. Exploratory analyses will assess correlations between craving and connectivity of other network pairs of the TNM.

ConclusionsThis report aims to identify functional neurobiological markers of craving during early abstinence in AUD employing normative models. Findings may advance understanding of relapse vulnerability and inform personalized interventions targeting large-scale brain network dysfunctions in AUD. This submission corresponds to Level 3 of the Peer Community In (PCI) Registered Report bias-control taxonomy: data were collected and pre-processed prior to hypothesis formulation, but key variables (subject-level values) have not been observed and no statistical analyses have been performed.
]]></description>
<dc:creator><![CDATA[ Salavrakos, M., Kumar, P., Cohen-Gilbert, J. E., Korponay, C., Hannon, K. A., Dricot, L., de Timary, P., Nickerson, L. D. ]]></dc:creator>
<dc:date>2026-03-17</dc:date>
<dc:identifier>doi:10.64898/2026.03.16.26348531</dc:identifier>
<dc:title><![CDATA[Preliminary investigation of between-network connectivity and craving during early alcohol abstinence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-03-17</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
